“Pharmacogenomics: Opportunities and Challenges for Health Innovation"

Prof. Howard McLeod, PharmD
Medical Director, Personalized Medicine Institute
Senior Member, Division of Population Sciences
Moffitt Cancer Center
United States

Howard McLeod is the Fred Eshelman Distinguished Professor of Pharmacogenomics and Individualized Therapy at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill and the director of the UNC Institute for Pharmacogenomics and Individualized Therapy. McLeod completed research fellowship training in cancer pharmacology at St. Jude Children’s Research Hospital in Memphis and at the University of Glasgow in Scotland. In 2000 he accepted a position at Washington University in St. Louis, Missouri, where he was a professor in the Departments of Medicine, Pharmacology and Molecular Biology, and Genetics and director of the Siteman Cancer Center Pharmacology Core. He is the principal investigator for the CREATE Pharmacogenetics Research Network, a member of the NIH funded Pharmacogenetics Research Network, and is a member of the FDA Committee on Clinical Pharmacology. He directs the Pharmacogenetics for Every Nation Initiative that aims to help developing countries use genetic information to improve National Drug Formulary decisions. Dr. McLeod has published more than 350 peer-reviewed papers on pharmacogenomics and individualized medicine.